Page last updated: 2024-08-23

phenyl acetate and Inflammatory Response Syndrome, Systemic

phenyl acetate has been researched along with Inflammatory Response Syndrome, Systemic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghoneim, HA; Khodir, AE; Rahim, MA; Suddek, GM1
Asahara, T; Hayakawa, K; Ikegawa, H; Kuwagata, Y; Matsushima, A; Nomoto, K; Ogura, H; Shimazu, T; Shimizu, K; Tasaki, O1
Ohno, H1
Abraham, E; Bandi, V; Dmitrienko, A; Farid, N; Forgue, ST; Gervich, D; Jiang, F; Lowry, SF; Macias, W; Naum, C; Schein, RM; Skerjanec, S; Wunderink, R1

Reviews

1 review(s) available for phenyl acetate and Inflammatory Response Syndrome, Systemic

ArticleYear
[Gut microbiota, host defense and immunity: analysis with integrative omics approach].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2014, Volume: 37, Issue:5

    Topics: Acetates; Animals; Apoptosis; Butyrates; Escherichia coli Infections; Escherichia coli O157; Fatty Acids, Volatile; Gene Expression Profiling; Genomics; Humans; Intestines; Metabolomics; Mice; Microbiota; Neutrophils; Receptors, G-Protein-Coupled; Signal Transduction; Systemic Inflammatory Response Syndrome; T-Lymphocytes, Regulatory; Toll-Like Receptors

2014

Trials

1 trial(s) available for phenyl acetate and Inflammatory Response Syndrome, Systemic

ArticleYear
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure.
    Critical care medicine, 2003, Volume: 31, Issue:3

    Topics: Acetates; Aged; Cause of Death; Critical Illness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Group II Phospholipases A2; Hospital Mortality; Humans; Indoles; Inflammation; Infusions, Intravenous; Keto Acids; Male; Middle Aged; Molecular Weight; Multiple Organ Failure; Phospholipases A; Phospholipases A2; Proportional Hazards Models; Prospective Studies; Safety; Survival Analysis; Systemic Inflammatory Response Syndrome; Time Factors; Treatment Outcome; United States

2003

Other Studies

2 other study(ies) available for phenyl acetate and Inflammatory Response Syndrome, Systemic

ArticleYear
Montelukast reduces sepsis-induced lung and renal injury in rats.
    Canadian journal of physiology and pharmacology, 2014, Volume: 92, Issue:10

    Topics: Acetates; Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Cyclopropanes; Kidney; Lipopolysaccharides; Lung; Male; Oxidative Stress; Quinolines; Random Allocation; Rats, Sprague-Dawley; Sulfides; Systemic Inflammatory Response Syndrome

2014
Gut microbiota and environment in patients with major burns – a preliminary report.
    Burns : journal of the International Society for Burn Injuries, 2015, Volume: 41, Issue:3

    Topics: Acetates; Adult; Aged; Bacteroidaceae; Bifidobacterium; Burns; Butyrates; Clostridium; Enterobacteriaceae; Enterococcus; Fatty Acids; Feces; Female; Gastrointestinal Microbiome; Humans; Lactobacillus; Male; Middle Aged; Multiple Organ Failure; Propionates; Pseudomonas; Staphylococcus; Systemic Inflammatory Response Syndrome

2015